3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
1
Adenocarcinoma
1
Interventions
Gemcitabine
13
Specimen Handling
12
Radiotherapy
12
Androgen Antagonists
12
Magnetic Resonance Spectroscopy
10
Nivolumab
9
pembrolizumab
8
darolutamide
7
Drug Therapy
7
toripalimab
6
Radiosurgery
6
Docetaxel
6
Cystectomy
6
enzalutamide
5
apalutamide
5
Mitomycin
5
Cisplatin
5
Abiraterone Acetate
5
disitamab vedotin
4
cabozantinib
4
abiraterone
4
Pluvicto
4
Ipilimumab
4
Cyclophosphamide
4
Biopsy
4
Axitinib
4
tislelizumab
3
lenvatinib
3
fludarabine
3
cemiplimab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Poly(ADP-ribose) Polymerase Inhibitors
×
Genitourinary
×
Clear all
NCT07268794
2025-12-08
CONVERT-HB1
Fudan University
Phase 2
Not yet recruiting
112 enrolled